Yüklüyor......

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors

BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kruser, Tim J., Wheeler, Deric L., Armstrong, Eric A., Iida, Mari, Kozak, Kevin R., van der Kogel, Albert J., Bussink, Johan, Coxon, Angela, Polverino, Anthony, Harari, Paul M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/
https://ncbi.nlm.nih.gov/pubmed/20507929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!